Lexicon Pharmaceuticals (LXRX) Free Cash Flow: 2009-2024
Historic Free Cash Flow for Lexicon Pharmaceuticals (LXRX) over the last 16 years, with Dec 2024 value amounting to -$179.8 million.
- Lexicon Pharmaceuticals' Free Cash Flow rose 9.49% to -$20.5 million in Q4 2012 from the same period last year, while for Dec 2012 it was -$95.0 million, marking a year-over-year decrease of 6.52%. This contributed to the annual value of -$179.8 million for FY2024, which is 10.74% down from last year.
- Latest data reveals that Lexicon Pharmaceuticals reported Free Cash Flow of -$179.8 million as of FY2024, which was down 10.74% from -$162.4 million recorded in FY2023.
- Lexicon Pharmaceuticals' Free Cash Flow's 5-year high stood at -$88.2 million during FY2021, with a 5-year trough of -$179.8 million in FY2024.
- Its 3-year average for Free Cash Flow is -$144.1 million, with a median of -$162.4 million in 2023.
- Per our database at Business Quant, Lexicon Pharmaceuticals' Free Cash Flow tumbled by 225.78% in 2020 and then soared by 38.32% in 2021.
- Over the past 5 years, Lexicon Pharmaceuticals' Free Cash Flow (Yearly) stood at -$143.1 million in 2020, then spiked by 38.32% to -$88.2 million in 2021, then decreased by 2.20% to -$90.2 million in 2022, then tumbled by 80.05% to -$162.4 million in 2023, then decreased by 10.74% to -$179.8 million in 2024.